Free Trial

Semler Scientific (SMLR) Competitors

Semler Scientific logo
$35.42 -3.32 (-8.57%)
Closing price 07/1/2025 04:00 PM Eastern
Extended Trading
$36.22 +0.81 (+2.27%)
As of 06:45 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SMLR vs. TNDM, SSII, CDRE, AORT, LQDA, FNA, ESTA, PLSE, BLFS, and MDXG

Should you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include Tandem Diabetes Care (TNDM), SS Innovations International (SSII), Cadre (CDRE), Artivion (AORT), Liquidia Technologies (LQDA), Paragon 28 (FNA), Establishment Labs (ESTA), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), and MiMedx Group (MDXG). These companies are all part of the "medical equipment" industry.

Semler Scientific vs. Its Competitors

Tandem Diabetes Care (NASDAQ:TNDM) and Semler Scientific (NASDAQ:SMLR) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends.

49.4% of Semler Scientific shares are owned by institutional investors. 1.9% of Tandem Diabetes Care shares are owned by insiders. Comparatively, 30.2% of Semler Scientific shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Tandem Diabetes Care has a net margin of -18.71% compared to Semler Scientific's net margin of -60.69%. Semler Scientific's return on equity of 19.75% beat Tandem Diabetes Care's return on equity.

Company Net Margins Return on Equity Return on Assets
Tandem Diabetes Care-18.71% -57.33% -13.48%
Semler Scientific -60.69%19.75%15.47%

Semler Scientific has lower revenue, but higher earnings than Tandem Diabetes Care. Semler Scientific is trading at a lower price-to-earnings ratio than Tandem Diabetes Care, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tandem Diabetes Care$940.20M1.22-$96.03M-$2.78-6.20
Semler Scientific$56.29M7.02$40.90M-$2.61-13.57

Tandem Diabetes Care presently has a consensus target price of $33.43, suggesting a potential upside of 93.90%. Semler Scientific has a consensus target price of $71.00, suggesting a potential upside of 100.45%. Given Semler Scientific's stronger consensus rating and higher possible upside, analysts plainly believe Semler Scientific is more favorable than Tandem Diabetes Care.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tandem Diabetes Care
0 Sell rating(s)
9 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.40
Semler Scientific
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Tandem Diabetes Care has a beta of 1.48, indicating that its share price is 48% more volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.39, indicating that its share price is 39% more volatile than the S&P 500.

In the previous week, Tandem Diabetes Care had 3 more articles in the media than Semler Scientific. MarketBeat recorded 9 mentions for Tandem Diabetes Care and 6 mentions for Semler Scientific. Tandem Diabetes Care's average media sentiment score of 1.27 beat Semler Scientific's score of 0.23 indicating that Tandem Diabetes Care is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tandem Diabetes Care
3 Very Positive mention(s)
4 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Semler Scientific
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Semler Scientific beats Tandem Diabetes Care on 9 of the 16 factors compared between the two stocks.

Get Semler Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SMLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMLR vs. The Competition

MetricSemler ScientificMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$432.01M$6.78B$5.48B$8.94B
Dividend YieldN/A1.04%5.38%4.12%
P/E Ratio-13.5727.0626.2219.74
Price / Sales7.0285.89405.42109.12
Price / Cash8.6621.0536.4957.06
Price / Book1.424.707.945.37
Net Income$40.90M$173.18M$3.15B$248.34M
7 Day Performance-13.69%0.20%0.77%1.67%
1 Month Performance-0.48%-1.11%3.47%4.56%
1 Year Performance8.15%24.36%34.86%18.42%

Semler Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMLR
Semler Scientific
2.3021 of 5 stars
$35.42
-8.6%
$71.00
+100.5%
+5.0%$432.01M$56.29M-13.57120
TNDM
Tandem Diabetes Care
4.2949 of 5 stars
$20.22
flat
$33.43
+65.3%
-56.3%$1.35B$940.20M-7.272,650Positive News
SSII
SS Innovations International
N/A$5.65
-18.4%
N/AN/A$1.34B$22.13M0.004Gap Down
CDRE
Cadre
3.6566 of 5 stars
$32.76
-0.3%
$37.50
+14.5%
-3.9%$1.34B$567.56M34.482,284Positive News
AORT
Artivion
2.7793 of 5 stars
$30.84
+1.9%
$32.00
+3.8%
+20.7%$1.29B$388.54M-61.671,600Positive News
LQDA
Liquidia Technologies
3.3727 of 5 stars
$13.26
+0.7%
$26.89
+102.8%
-0.3%$1.13B$14M-8.3950
FNA
Paragon 28
0.5019 of 5 stars
$13.11
+0.1%
$12.75
-2.7%
+99.5%$1.10B$256.18M-17.71343,000High Trading Volume
ESTA
Establishment Labs
1.3976 of 5 stars
$36.58
-3.3%
$52.40
+43.2%
+0.1%$1.09B$166.02M-11.801,018
PLSE
Pulse Biosciences
1.355 of 5 stars
$15.49
+1.2%
N/A+37.0%$1.03B$700K0.00140
BLFS
BioLife Solutions
3.0631 of 5 stars
$21.36
+0.7%
$31.17
+45.9%
+4.2%$1.01B$82.25M-73.65440Positive News
MDXG
MiMedx Group
3.7107 of 5 stars
$5.94
+2.2%
$12.50
+110.4%
-7.2%$858.15M$348.88M22.00870

Related Companies and Tools


This page (NASDAQ:SMLR) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners